Literature DB >> 11301666

Drugs and syringe drivers: a survey of adult specialist palliative care practice in the United Kingdom and Eire.

C A O'Doherty1, E J Hall, L Schofield, G Zeppetella.   

Abstract

Subcutaneous delivery of drugs using a syringe driver is common practice within specialist palliative care units. There is, however, little documented information regarding clinical practice. A survey performed in 1992 reported that at least 28 drugs were used in combination with others in a single syringe driver. The aim of the present study was to reassess practice in this field and to enquire more specifically about newer drugs. Postal questionnaires were sent to all adult specialist palliative care in-patient units in the UK and Eire (n = 208). One hundred and sixty-five units (79%) responded. The most common syringe driver in use was the Graseby 26 (61% of responding units). Most units delivered the contents of the syringe over 24 h, and water was usually used as the diluent in 90% of cases. The maximum number of drugs that respondents were prepared to mix in a single syringe was usually three (51%) or four (35%). In the UK, all units used diamorphine in doses from 2.5 mg/24 h upwards. All respondents also used haloperidol, in doses from 0.5 to 60 mg/24 h. A total of 28 different drugs were used in syringe drivers. The most common combinations were diamorphine and midazolam (37%), diamorphine and levomepromazine (35%), diamorphine and haloperidol (33%), and diamorphine and cyclizine (31%). In conclusion, there is much in common with regard to the way in which drugs are delivered in syringe drivers. However, a wide variety of drugs and drug combinations are still in use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301666     DOI: 10.1191/026921601666624292

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  5 in total

1.  [Palliative care: care in the final days].

Authors:  M A Benítez del Rosario; L Pascual; A Asensio Fraile
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

2.  [Under what conditions is subcutaneous administration of fluid indicated].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

3.  Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?

Authors:  Sasson Menahem; Pesach Shvartzman
Journal:  Support Care Cancer       Date:  2009-09-30       Impact factor: 3.603

4.  Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.

Authors:  Andrew Dickman; Matthew Bickerstaff; Richard Jackson; Jennifer Schneider; Stephen Mason; John Ellershaw
Journal:  BMC Palliat Care       Date:  2017-03-23       Impact factor: 3.234

5.  Diamorphine for pain and distress in young patients: case examples and discussion of mechanisms.

Authors:  Caradoc Morris
Journal:  BMJ Support Palliat Care       Date:  2021-12-02       Impact factor: 3.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.